SETD1A and Neurodevelopmental delay: Of all the identified disease-associated SETD1A mutations [17–19], a two-base deletion at the exon 16 splice acceptor (c.4582-2delAG) is a recurring one that is most frequently carried by SCZ patients (four reported cases) and other NDD patients (three incidences) [8].